Ewha Med J.
2016 Oct;39(4):122-124. 10.12771/emj.2016.39.4.122.
Anti-tuberculosis Treatment-Induced Insulin Autoimmune Syndrome
- Affiliations
-
- 1Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. chorong24@gmail.com
- KMID: 2356384
- DOI: http://doi.org/10.12771/emj.2016.39.4.122
Abstract
- Insulin autoimmune syndrome, a rare cause of endogenous hyperinsulinemic hypoglycemia, is characterized by insulin autoantibody, hyperinsulinemia and fasting hypoglycemia. It is well known that drugs containing a sulfhydryl group such as methimazole or α-mercaptopropionyl glycine can induce insulin autoimmune syndrome. However, insulin autoimmune syndrome caused by anti-tuberculosis treatment is very rare. We report a case of insulin autoimmune syndrome after anti-tuberculosis treatment with a review of the relevant literature.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of autoimmune hypoglycemia during treatment with anti-tuberculosis drugs
- Methimazole-Induced Insulin Autoimmune Syndrome in a Korean Patient with Graves’ Disease Treated with Propylthiouracil: a Case Report and Literature Review
- A Case of Polygrandular Automune type II syndrome associated empty sella
- Insulin Autoimmune Syndrome with Diabetic Ketoacidosis
- Insulin Autoimmune Syndrome in a Patient with Hashimoto's Thyroiditis
